[Surgical treatment of isolated tricuspid valve disease: indications, new evidence, and risk stratification]

Marco Russo,Antonio Giovanni Cammardella,Francesco Loreni,Francesco Irace,Grazia Santoro,Vittoria Lodo,Matteo Matteucci,Gianpiero Buttiglione,Alessandra Francica,Michele Di Mauro,Francesco Pollari,Federico Ranocchi,Fabio Barili,Alessandro Parolari,Francesco Musumeci,a nome della Task Force SICCH Young della Società Italiana di Chirurgia Cardiaca
DOI: https://doi.org/10.1714/4309.42928
Abstract:The tricuspid valve, long neglected as a passive structure and often termed the "forgotten valve", has recently gained attention from the international medical and cardiological community due to the association of tricuspid regurgitation with an unfavorable prognosis. Isolated tricuspid regurgitation represents a relatively unknown and variable condition, closely linked to the shape and function of the right ventricle and the state of the pulmonary circulation. Currently, guidelines are not clear regarding the optimal treatment strategy, the process of patient selection, and the surgical or transcatheter procedural timing, nor for predicting patient outcomes. Surgical procedures specifically aimed at correcting isolated tricuspid regurgitation, without other concomitant indications for open-heart surgery, have been considered complex and risky, with a high rate of postoperative complications and a poorly understood impact on patient survival and life expectancy. In this review, we will attempt to examine tricuspid valve pathology by analyzing preoperative assessment, essential for risk stratification, various surgical techniques, and outcomes.
What problem does this paper attempt to address?